Cargando…

Mutant HbpR transcription activator isolation for 2‐chlorobiphenyl via green fluorescent protein‐based flow cytometry and cell sorting

Mutants were produced in the A‐domain of HbpR, a protein belonging to the XylR family of σ(54)‐dependent transcription activators, with the purpose of changing its effector recognition specificity from 2‐hydroxybiphenyl (2‐HBP, the cognate effector) to 2‐chlorobiphenyl (2‐CBP). Mutations were introd...

Descripción completa

Detalles Bibliográficos
Autores principales: Beggah, Siham, Vogne, Christelle, Zenaro, Elena, Van Der Meer, Jan Roelof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864433/
https://www.ncbi.nlm.nih.gov/pubmed/21261823
http://dx.doi.org/10.1111/j.1751-7915.2007.00008.x
Descripción
Sumario:Mutants were produced in the A‐domain of HbpR, a protein belonging to the XylR family of σ(54)‐dependent transcription activators, with the purpose of changing its effector recognition specificity from 2‐hydroxybiphenyl (2‐HBP, the cognate effector) to 2‐chlorobiphenyl (2‐CBP). Mutations were introduced in the hbpR gene part for the A‐domain via error‐prone polymerase chain reaction, and assembled on a gene circuitry plasmid in Escherichia coli, permitting HbpR‐dependent induction of the enhanced green fluorescent protein (egfp). Cells with mutant HbpR proteins responsive to 2‐CBP were enriched and separated in a flow cytometry‐assisted cell‐sorting procedure. Some 70 mutants were isolated and the A‐domain mutations mapped. One of these had acquired true 2‐CBP recognition but reacted hypersensitively to 2‐HBP (20‐fold more than the wild type), whereas others had reduced sensitivity to 2‐HBP but a gain of 2‐CBP recognition. Sequencing showed that most mutants carried double or triple mutations in the A‐domain gene part, and were not located in previously recognized conserved residues within the XylR family members. Further selection from a new mutant pool prepared of the hypersensitive mutant did not result in increased 2‐CBP or reduced 2‐HBP recognition. Our data thus demonstrate that a one‐step in vitro‘evolutionary’ adaptation of the HbpR protein can result in both enhancement and reduction of the native effector recognition.